Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.1%

85 terminated/withdrawn out of 2053 trials

Success Rate

92.7%

+6.1% vs industry average

Late-Stage Pipeline

15%

310 trials in Phase 3/4

Results Transparency

8%

81 of 1076 completed trials have results

Key Signals

180 recruiting81 with results55 terminated30 withdrawn

Enrollment Performance

Analytics

N/A
907(58.6%)
Phase 4
225(14.5%)
Phase 2
208(13.4%)
Phase 1
110(7.1%)
Phase 3
85(5.5%)
Early Phase 1
12(0.8%)
1547Total
N/A(907)
Phase 4(225)
Phase 2(208)
Phase 1(110)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2053)

Showing 20 of 2053 trials
NCT05534087Phase 3Recruiting

Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)

Role: lead

NCT07410988Phase 4Recruiting

Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications

Role: lead

NCT06184009Phase 2Recruiting

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

Role: collaborator

NCT05827549Phase 2Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT07735130Phase 4Not Yet Recruiting

Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

Role: lead

NCT07732296Not ApplicableNot Yet Recruiting

Distal Versus Conventional Radial Arterial Catheterization for Arterial Waveform Stability

Role: lead

NCT07732426Not ApplicableRecruiting

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Role: lead

NCT07722078Not Yet Recruiting

Clinical Validation of SMD-AFECG for Predicting New-Onset Atrial Fibrillation Within 2 Hours Using Single-Lead ECG Data

Role: collaborator

NCT07486739Not ApplicableNot Yet Recruiting

Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation

Role: lead

NCT07722039Not Yet Recruiting

Clinical Validation of SMD-RVECG for Predicting Atrial Fibrillation With Rapid Ventricular Response Within 2 Hours

Role: collaborator

NCT05005715Phase 2Completed

Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Role: lead

NCT07708155Not ApplicableCompleted

Generative AI-Assisted Clinical Decision Support for Medical Intensive Care Unit Physicians

Role: lead

NCT05148286Phase 4Recruiting

Albumin and Crystalloid Administration in Septic Shock

Role: collaborator

NCT07704723Not ApplicableNot Yet Recruiting

First Attempt Success in Tracheal Intubation Through Supraglottic Airway Devices Without Fiberoptic Guidance

Role: lead

NCT07699744Phase 4Not Yet Recruiting

Intravenous Dexamethasone With Single-Shot Versus Continuous Brachial Plexus Block for Rebound Pain After Shoulder Surgery

Role: lead

NCT06225453Not ApplicableRecruiting

Individualized Versus Conventional Perioperative Blood Pressure Management

Role: lead

NCT07683949Phase 1Enrolling By Invitation

Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine

Role: collaborator

NCT07682480Not ApplicableNot Yet Recruiting

Comparison of First Attempt Success Based on Endotracheal Tube Type During Videolaryngoscope-guided Intubation Without Stylet

Role: lead

NCT07675954Phase 3Not Yet Recruiting

A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis

Role: lead